Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000910680-03-000254
Filing Date
2003-03-17
Accepted
2003-03-17 17:08:25
Documents
9
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K 12/31/2002 f10k123102.txt 10-K 303832
3 10.2- ROBERT STOTE EMPLOYMENT AGMT empagstote-1231200210k.txt EX-10 35095
4 10.10 - AMEND NO. 3 TO LICENSE AGMT amdtno3-12312992.txt EX-10 5067
5 EX-10.11 - LETTER DATED 11/4/02 pfizerletter-10k12312002.txt EX-10 1958
6 EX-10.12 - BENTLEY & AUXILIUM licenseagmt10k032003.txt EX-10 43375
7 10.13 - AMEND NO. 1 TO LICENSE AGMT amdtno1-10k12312002.txt EX-10 4906
8 LIST OF SUBSIDIARIES exh21_123102.txt EX-21 1157
9 CONSENT ex23_1.txt EX-23 749
10 EXH 99.1 - 99.2 exh99123102.txt EX-99 2474
  Complete submission text file 0000910680-03-000254.txt   401266
Mailing Address 65 LAFAYETTE RD 3RD FLR NORTH HAMPTON NH 03862
Business Address 65 LAFAYETTE RD 3RD FLR NORTH HAMPTON NH 03862 6039648006
BENTLEY PHARMACEUTICALS INC (Filer) CIK: 0000821616 (see all company filings)

EIN.: 591513162 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-10581 | Film No.: 03606461
SIC: 2834 Pharmaceutical Preparations